Diabetes management, dietary supplements use and the effect of coronavirus pandemic on diabetes patients in Serbia: a cross-sectional study

References

• World Health Organization (WHO). Diabetes. Key facts. [Internet]. 2021 [cited 2022 Jun 6]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes.
   Google Scholar
• World Health Organization (WHO). – Regional office for Europe. Health topics. Noncommunicable diseases. Diabetes. Data and statistics [Internet]. [cited 2022 Jun 6]. Available from: https://www.who.int/news-room/fact-sheets/detail/diabetes.
   Google Scholar
• Incidence and mortality of diabetes in Serbia 2020. [Internet]. [cited 2022 Jun 6]. Available from: https://www.batut.org.rs/download/publikacije/Dijabetes2020.pdf.
   Google Scholar
• Karuranga S, Malanda B, Saeedi P, et al. editors. IDF diabetes atlas. [Internet]. Ninth edition. Brussels: International Diabetes Federation; 2019 [cited 2023 Jun 5]. Available from: https://diabetesatlas.org/upload/resources/material/20200302_133351_IDFATLAS9e-final-web.pdf.
   Google Scholar
• Hannon BA, Fairfield WD, Adams B, et al. Use and abuse of dietary supplements in persons with diabetes. Nutr Diabetes. 2020;10(1):14. doi: 10.1038/s41387-020-0117-6.
   PubMed Web of Science ®Google Scholar
• Aysin E, Urhan M. Dramatic increase in dietary supplement use during covid-19. Curr Dev Nutr. 2021;5:207. doi:10.1093/cdn/nzab029_008.
   Google Scholar
• Hamulka J, Jeruszka-Bielak M, Górnicka M, et al. Dietary supplements during COVID-19 outbreak. Results of google trends analysis supported by PLifeCOVID-19 online studies. Nutrients. 2020;13(1):54. doi:10.3390/nu13010054.
   PubMed Web of Science ®Google Scholar
• Sabico S, Enani MA, Sheshah E, et al. Effects of a 2-Week 5000 IU versus 1000 IU vitamin D3 supplementation on recovery of symptoms in patients with mild to moderate covid-19: a randomized clinical trial. Nutrients. 2021;13(7):2170. doi:10.3390/nu13072170.
   PubMed Web of Science ®Google Scholar
• Cerullo G, Negro M, Parimbelli M, et al. The long history of vitamin C: from prevention of the common cold to potential aid in the treatment of COVID-19. Front Immunol. 2020;11:574029. doi:10.3389/fimmu.2020.574029.
   PubMed Web of Science ®Google Scholar
• Pal A, Squitti R, Picozza M, et al. Zinc and COVID-19: basis of current clinical trials. Biol Trace Elem Res. 2021;199(8):2882–2892. doi:10.1007/s12011-020-02437-9.
   PubMed Web of Science ®Google Scholar
• McCarty MF, Iloki Assanga SB, Lewis Luján L, et al. Nutraceutical strategies for suppressing NLRP3 inflammasome activation: pertinence to the management of COVID-19 and Beyond. Nutrients. 2020;13(1):47. doi:10.3390/nu13010047.
   PubMed Web of Science ®Google Scholar
• Izzo R, Trimarco V, Mone P, et al. Combining L-arginine with vitamin C improves long-COVID symptoms: the LINCOLN survey. Pharmacol Res. 2022;183:106360. doi:10.1016/j.phrs.2022.106360.
   PubMed Web of Science ®Google Scholar
• Kazemi A, Ryul Shim S, Jamali N, et al. Comparison of nutritional supplements for glycemic control in type 2 diabetes: a systematic review and network meta-analysis of randomized trials. Diabetes Res Clin Pract. 2022;191:110037. doi:10.1016/j.diabres.2022.110037.
   PubMed Web of Science ®Google Scholar
• Aktas G, Balci B, Yilmaz S, et al. Characteristics of covid-19 infection with the original SARS-Cov-2 virus and other variants: a comparative review. J Bionic Mem. 2022;2:96–112. doi:10.53545/jbm.2022.22.
   Google Scholar
• Kocak MZ, Aktas G, Erkus E, et al. Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus. Swiss Med Wkly. 2019;149:w20139. doi:10.4414/smw.2019.20139.
   PubMed Web of Science ®Google Scholar
• Atak Tel BM, Bilgin S, Kurtkulagi O, et al. Frailty in diabetic subjects during COVID-19 and its association with HbA1c, mean platelet volume and monocyte/lymphocyte ratio. Clin Diabetol. 2022;11(2):119–126. doi:10.5603/DK.a2022.0015.
   Web of Science ®Google Scholar
• Mohseni M, Ahmadi S, Azami-Aghdash S, et al. Challenges of routine diabetes care during COVID-19 era: a systematic search and narrative review. Prim Care Diabetes. 2021;15(6):918–922. doi:10.1016/j.pcd.2021.07.017.
   PubMed Web of Science ®Google Scholar
• Ranscombe P. How diabetes management is adapting amid the COVID-19 pandemic. Lancet Diabetes Endocrinol. 2020;8(7):571. doi:10.1016/S2213-8587(20)30181-9.
   PubMed Web of Science ®Google Scholar
• Scott ES, Jenkins AJ, Fulcher GR. Challenges of diabetes management during the COVID‐19 pandemic. Med J Aust. 2020;213(2):56–57.e1. doi:10.5694/mja2.50665.
   PubMed Web of Science ®Google Scholar
• Patel SY, McCoy RG, Barnett ML, et al. Diabetes care and glycemic control during the COVID-19 pandemic in the United States. JAMA Intern Med. 2021;181(10):1412–1414. doi:10.1001/jamainternmed.2021.3047.
   PubMed Web of Science ®Google Scholar
• Fernández E, Cortazar A, Bellido V. Impact of COVID-19 lockdown on glycemic control in patients with type 1 diabetes. Diabetes Res Clin Pract. 2020;166:108348. doi:10.1016/j.diabres.2020.108348.
   PubMed Web of Science ®Google Scholar
• Stockwell S, Trott M, Tully M, et al. Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review. BMJ Open Sport Exerc Med. 2021;7(1):e000960. doi:10.1136/bmjsem-2020-000960.
   PubMedGoogle Scholar
• Chang HA, Wallis M, Tiralongo E. Use of complementary and alternative medicine among people with type 2 diabetes in Taiwan: a cross-sectional survey. Evid Based Complement Alternat Med. 2011;2011:1–8. doi:10.1155/2011/983792.
   Web of Science ®Google Scholar
• Nachimuthu S, Vijayalakshmi R, Sudha M, et al. Coping with diabetes during the COVID – 19 lockdown in India: results of an online pilot survey. Diabetes Metab Syndr. 2020;14(4):579–582. doi:10.1016/j.dsx.2020.04.05.
   PubMed Web of Science ®Google Scholar
• Zagrebačko dijabetičko društvo. Šećerna bolest u RH – ispuni anketu Internet]. 2019. Available from: https://www.zadi.hr/.
   Google Scholar
• Lawshe CH. A quantitative approach to content validity. Pers Psychol. 1975;28(4):563–575. doi:10.1111/j.1744-6570.1975.tb01393.x.
   Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843.
   PubMed Web of Science ®Google Scholar
• Incidence and mortality of diabetes in Serbia. 2021 [Internet]. Available from: https://www.batut.org.rs/download/publikacije/Incidencija%20i%20mortalitet%20od%20dijabetesa%20u%20Srbiji%202021.pdf.
   Google Scholar
• Farmer A, Balman E, Gadsby R, et al. Frequency of self-monitoring of blood glucose in patients with type 2 diabetes: association with hypoglycaemic events. Curr Med Res Opin. 2008;24(11):3097–3104. doi:10.1185/03007990802473062.
   PubMed Web of Science ®Google Scholar
• DeSalvo DJ, Noor N, Xie C, et al. Patient demographics and clinical outcomes among type 1 diabetes patients using continuous glucose monitors: data from T1D exchange real-world observational study. J Diabetes Sci Technol. 2023;17(2):322–328. doi:10.1177/19322968211049783.
   PubMedGoogle Scholar
• Pitocco D, Laurenzi A, Tomaselli L, et al. Health care organization and use of technological devices in people with diabetes in Italy: results from a survey of the working group on diabetes and technology. Nutr Metab Cardiovasc Dis. 2022;32(10):2392–2398. doi:10.1016/j.numecd.2022.07.003.
   PubMed Web of Science ®Google Scholar
• Jackson MA, Ahmann A, Shah VN. Type 2 diabetes and the use of real-time continuous glucose monitoring. Diabetes Technol Ther. 2021;23(S1):S27–S34. doi:10.1089/dia.2021.0007.
   PubMedGoogle Scholar
• Kompala T, Neinstein A. A new era: increasing continuous glucose monitoring use in type 2 diabetes. Am J Manag Care. 2019;25(4 Spec No):SP123–SP126.
   PubMedGoogle Scholar
• Bao S, Bailey R, Calhoun P, et al. Effectiveness of continuous glucose monitoring in older adults with type 2 diabetes treated with basal insulin. Diabetes Technol Ther. 2022;24(5):299–306. doi:10.1089/dia.2021.0494.
   PubMed Web of Science ®Google Scholar
• Janapala RN, Jayaraj JS, Fathima N, et al. Continuous glucose monitoring versus self-monitoring of blood glucose in type 2 diabetes mellitus: a systematic review with meta-analysis. Cureus. 2019;11(9):e5634. doi:10.7759/cureus.5634.
   PubMed Web of Science ®Google Scholar
• Azhar S, Khan FZ, Khan ST, et al. Raised glycated hemoglobin (HbA1c) level as a risk factor for myocardial infarction in diabetic patients: a hospital-based, cross-sectional study in Peshawar. Cureus. 2022;14(6):e25723. doi:10.7759/cureus.25723.
   PubMed Web of Science ®Google Scholar
• Sherwani SI, Khan HA, Ekhzaimy A, et al. Significance of HbA1c test in diagnosis and prognosis of diabetic patients. Biomark Insights. 2016;11(S38440):95–104. doi:10.4137/BMI.S38440.
   PubMedGoogle Scholar
• Cokolic M, Lalic NM, Micic D, et al. Patterns of diabetes care in Slovenia, Croatia, serbia, Bulgaria and Romania. Wien Klin Wochenschr. 2017;129(5-6):192–200. doi:10.1007/s00508-016-1143-1.
   PubMed Web of Science ®Google Scholar
• Ejeta A, Abdosh T, Hawulte B, et al. Diabetes concordant comorbidities and associated factors among adult diabetic out-patients at hiwot fana specialized university hospital, harar, Eastern Ethiopia: a cross-sectional study. Diabetes Metab Syndr Obes. 2021;14:2281–2289. doi:10.2147/DMSO.S308553.
   PubMed Web of Science ®Google Scholar
• Martínez-Ortega AJ, Muñoz-Gómez C, Gros-Herguido N, et al. Description of a cohort of type 1 diabetes patients: analysis of comorbidities, prevalence of complications and risk of hypoglycemia. J Clin Med. 2022;11(4):1039. doi:10.3390/jcm11041039.
   PubMed Web of Science ®Google Scholar
• Iglay K, Hannachi H, Joseph Howie P, et al. Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus. Curr Med Res Opin. 2016;32(7):1243–1252. doi:10.1185/03007995.2016.1168291.
   PubMed Web of Science ®Google Scholar
• Kim HS, Shin AM, Kim MK, et al. Comorbidity study on type 2 diabetes mellitus using data mining. Korean J Intern Med. 2012;27(2):197–202. doi:10.3904/kjim.2012.27.2.197.
   PubMed Web of Science ®Google Scholar
• Schutta MH. Diabetes and hypertension: epidemiology of the relationship and pathophysiology of factors associated with these comorbid conditions. J Cardiometab Syndr. 2007;2(2):124–130. doi:10.1111/j.1559-4564.2007.06368.x.
   PubMedGoogle Scholar
• Oktora MP, Alfian SD, Bos HJ, et al. Trends in polypharmacy and potentially inappropriate medication (PIM) in older and Middle‐aged people treated for diabetes. Br J Clin Pharmacol. 2021;87(7):2807–2817. doi:10.1111/bcp.14685.
   PubMed Web of Science ®Google Scholar
• Thi Bui DH, Nguyen BX, Truong DC, et al. Polypharmacy among people living with type 2 diabetes mellitus in rural communes in Vietnam. PLOS One. 2021;16(4):e0249849. doi:10.1371/journal.pone.0249849.
   PubMed Web of Science ®Google Scholar
• Bauer S, Nauck MA. Polypharmacy in people with type 1 and type 2 diabetes is justified by current guidelines-a comprehensive assessment of drug prescriptions in patients needing inpatient treatment for diabetes-associated problems. Diabet Med. 2014;31(9):1078–1085. doi:10.1111/dme.12497.
   PubMed Web of Science ®Google Scholar
• Jovičić-Bata J, Grujičić M, Novaković B, et al. Epidemiology of dietary supplement use in Serbia: report from novi sad. Complement Ther Med. 2019;47:102228. doi:10.1016/j.ctim.2019.102228.
   PubMed Web of Science ®Google Scholar
• Alowais M, Selim ME-H. Knowledge, attitude, and practices regarding dietary supplements in Saudi Arabia. J Family Med Prim Care. 2019;8(2):365–372. doi:10.4103/jfmpc.jfmpc_430_18.
   PubMedGoogle Scholar
• Mishra S, Stierman B, Gahche J, et al. Dietary supplement use among adults: United States, 2017–2018. Hyattsville, MD. NCHS Data Brief. 2021;(399):1–8.
   PubMedGoogle Scholar
• Schuetz P, Gregoriano C, Keller U. Supplementation of the population during the COVID-19 pandemic with vitamins and micronutrients – how much evidence is needed? Swiss Med Wkly. 2021;151(1920):w20522. doi:10.4414/smw.2021.20522.
   PubMedGoogle Scholar
• Hadizadeh F. Supplementation with vitamin D in the COVID-19 pandemic? Nutr Rev. 2021;79(2):200–208. doi:10.1093/nutrit/nuaa081.
   PubMed Web of Science ®Google Scholar
• Puścion-Jakubik A, Bielecka J, Grabia M, et al. Consumption of food supplements during the three COVID-19 waves in Poland—focus on zinc and vitamin D. Nutrients. 2021;13(10):3361. doi:10.3390/nu13103361.
   PubMed Web of Science ®Google Scholar
• Ali RM, Al-Shorbagy MY, Helmy MW, et al. Role of Wnt4/β-catenin, ang II/TGFβ, ACE2, NF-κB, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with vit D and pioglitazone. Eur J Pharmacol. 2018;831:68–76. doi:10.1016/j.ejphar.2018.04.032.
   PubMed Web of Science ®Google Scholar
• Aygun H. Vitamin D can prevent COVID-19 infection-induced multiple organ damage. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(7):1157–1160. doi:10.1007/s00210-020-01911-4.
   PubMed Web of Science ®Google Scholar
• Porri D, Biesalski HK, Limitone A, et al. Effect of magnesium supplementation on women’s health and well-being. Nfs J. 2021;23:30–36. doi:10.1016/j.nfs.2021.03.003.
   Google Scholar
• Domitrz I, Cegielska J. Magnesium as an important factor in the pathogenesis and treatment of migraine—from theory to practice. Nutrients. 2022;14(5):1089. doi:10.3390/nu14051089.
   PubMed Web of Science ®Google Scholar
• Zhang S, Yang K, Zeng L, et al. Effectiveness of coenzyme Q10 supplementation for type 2 diabetes mellitus: a systematic review and meta-analysis. Int J Endocrinol. 2018;2018:6484839. doi:10.1155/2018/6484839.
   PubMed Web of Science ®Google Scholar
• Claxton L, Simmonds M, Beresford L, et al. Coenzyme Q10 to manage chronic heart failure with a reduced ejection fraction: a systematic review and economic evaluation. Health Technol Assess. 2022;26(4):1–128. doi:10.3310/KVOU6959.
   PubMed Web of Science ®Google Scholar
• Arenas‐Jal M, Suñé‐Negre JM, García‐Montoya E. Coenzyme Q10 supplementation: efficacy, safety, and formulation challenges. Comp Rev Food Sci Food Safe. 2020;19(2):574–594. doi:10.1111/1541-4337.12539.
   PubMed Web of Science ®Google Scholar
• Skulas-Ray AC, Wilson PWF, Harris WS, et al. Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American heart association. Circulation. 2019;140(12):e673–e691. doi:10.1161/CIR.0000000000000709.
   PubMed Web of Science ®Google Scholar
• Backes J, Anzalone D, Hilleman D, et al. The clinical relevance of omega-3 fatty acids in the management of hypertriglyceridemia. Lipids Health Dis. 2016;15(1):118. doi:10.1186/s12944-016-0286-4.
   PubMed Web of Science ®Google Scholar
• Arca M, Borghi C, Pontremoli R, et al. Hypertriglyceridemia and omega-3 fatty acids: their often overlooked role in cardiovascular disease prevention. Nutr Metab Cardiovasc Dis. 2018;28(3):197–205. doi:10.1016/j.numecd.2017.11.001.
   PubMed Web of Science ®Google Scholar
• Gao L, Lin L, Shan N, et al. The impact of omega-3 fatty acid supplementation on glycemic control in patients with gestational diabetes: a systematic review and meta-analysis of randomized controlled studies. Journal Matern Fetal Neonatal Med. 2020;33(10):1767–1773. doi:10.1080/14767058.2018.1526916.
   PubMed Web of Science ®Google Scholar
• Odegard PS, Janci MM, Foeppel MP, et al. Prevalence and correlates of dietary supplement use in individuals with diabetes mellitus at an academic diabetes care clinic. Diabetes Educ. 2011;37(3):419–425. doi:10.1177/0145721711401668.
   PubMed Web of Science ®Google Scholar
• Aktas G. Association between the prognostic nutritional index and chronic microvascular complications in patients with type 2 diabetes mellitus. J Clin Med. 2023;12(18):5952. doi:10.3390/jcm12185952.
   PubMed Web of Science ®Google Scholar
• Chaturvedi SK, Manche Gowda S, Ahmed HU, et al. More anxious than depressed: prevalence and correlates in a 15-nation study of anxiety disorders in people with type 2 diabetes mellitus. Gen Psychiatr. 2019;32(4):e100076. doi:10.1136/gpsych-2019-100076.
   PubMed Web of Science ®Google Scholar
• Mendes R, Martins S, Fernandes L. Adherence to medication, physical activity and diet in older adults with diabetes: its association with cognition, anxiety and depression. J Clin Med Res. 2019;11(8):583–592. doi:10.14740/jocmr3894.
   PubMedGoogle Scholar
• Alvarado-Martel D, Ruiz Fernández MÁ, Cuadrado Vigaray M, et al. Identification of psychological factors associated with adherence to self-care behaviors amongst patients with type 1 diabetes. J Diabetes Res. 2019;2019:6271591–6271599. doi:10.1155/2019/6271591.
   PubMed Web of Science ®Google Scholar
• Déniz-García A, Díaz-Artiles A, Saavedra P, et al. Impact of anxiety, depression and disease-related distress on long-term glycaemic variability among subjects with type 1 diabetes mellitus. BMC Endocr Disord. 2022;22(1):122. doi:10.1186/s12902-022-01013-7.
   PubMed Web of Science ®Google Scholar
• Sisman P, Polat I, Aydemir E, et al. How the COVID-19 outbreak affected patients with diabetes mellitus? Int J Diabetes Dev Ctries. 2022;42(1):53–61. doi:10.1007/s13410-021-00992-y.
   PubMed Web of Science ®Google Scholar
• Janzen Claude JA, Hadjistavropoulos HD, Friesen L. Exploration of health anxiety among individuals with diabetes: prevalence and implications. J Health Psychol. 2014;19(2):312–322. doi:10.1177/1359105312470157.
   PubMed Web of Science ®Google Scholar
• Moynihan R, Sanders S, Michaleff ZA, et al. Impact of COVID-19 pandemic on utilisation of healthcare services: a systematic review. BMJ Open. 2021;11(3):e045343. doi:10.1136/bmjopen-2020-045343.
   PubMed Web of Science ®Google Scholar
• Casciato DJ, Yancovitz S, Thompson J, et al. Diabetes-related major and minor amputation risk increased during the COVID-19 pandemic. J Am Podiatr Med Assoc. 2023;113(2):20–224. doi:10.7547/20-224.
   PubMed Web of Science ®Google Scholar
• Viswanathan V, Nachimuthu S. Major lower-limb amputation during the COVID pandemic in South India. Int J Low Extrem Wounds. 2021;22(3):475–479. doi:10.1177/15347346211020985.
   PubMed Web of Science ®Google Scholar
• Visacri MB, Figueiredo IV, Lima T de M. Role of pharmacist during the COVID-19 pandemic: a scoping review. Res Social Adm Pharm. 2021;17(1):1799–1806. doi:10.1016/j.sapharm.2020.07.003.
   PubMed Web of Science ®Google Scholar